These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3551414)

  • 1. [Purification of a corpuscular influenza vaccine by means of immunoaffinity chromatography].
    Zhebrun AB; Noskov FS; Polianskaia NIu; Bichurina MA; Fridman EA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jan; (1):45-9. PubMed ID: 3551414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Improved methods of controlling the purity and activity of inactivated influenza vaccines].
    Noskov FS; Bichurina MA; Zhebrun AB; Polianskaia NIu; Kaplun IIa
    Vopr Virusol; 1985; 30(4):409-13. PubMed ID: 3933181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of ELISA and radial immunodiffusion tests for evaluation of the degree of purification of influenza diagnostic and vaccine preparations].
    Paszkowska M; Jankowski M
    Med Dosw Mikrobiol; 1991; 43(3-4):135-43. PubMed ID: 1823376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Different Methods of Purification and Concentration in Production of Influenza Vaccine.
    Asanzhanova NN; Ryskeldinova SZ; Chervyakova OV; Khairullin BM; Kasenov MM; Tabynov KK
    Bull Exp Biol Med; 2017 Dec; 164(2):229-232. PubMed ID: 29177903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunobiological characteristics of impurities in corpuscular influenza vaccines].
    Zhebrun AB; Bichurina MA; Polianskaia NIu; Rozaeva NR; Fridman EA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Dec; (12):52-5. PubMed ID: 3825357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of the immunochemical purity of modern influenza vaccines].
    Zhebrun AB; Polianskaia NIu; Bichurina MA; Rozaeva NR; Fridman EA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):56-9. PubMed ID: 3799103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adsorbed subunit influenza vaccine: its isolation and characteristics].
    Shapiro NI; Zhukova TIa; Shpiliuk GF; Entina NN; Konstantinov VK
    Virologie; 1986; 37(2):125-9. PubMed ID: 3727396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of affinity purified antibodies for immunoenzyme determination of ovalbumin in influenza virus concentrates and influenza vaccines].
    Kapitanova NA; Khimchenko VP
    Tr Inst Im Pastera; 1988; 64():133-5. PubMed ID: 3077712
    [No Abstract]   [Full Text] [Related]  

  • 9. [Selection of the influenza virus vaccinal strain by means of crossed protection experiments on mice].
    Briantseva EA
    Tr Inst Im Pastera; 1976; 47():19-23. PubMed ID: 1088724
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sensitizing action of nonvirion admixtures in inactivated influenza vaccines in an experiment].
    Bichurina MA; Rozaeva NR; Polianskaia NIu; Zhebrun AB; Barashkova LN
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Dec; (12):36-9. PubMed ID: 6528779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laboratory control of the purity of chromatographic influenza vaccine].
    Bichurina MA; Goriunova VV; Zhebrun AB; Chubarova NI
    Tr Inst Im Pastera; 1979; 52():121-8. PubMed ID: 121646
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunogenicity of inactivated influenza vaccine, purified by adsorption chromatography on porous glas.
    Bresler S; Kolikov V; Katushkina N; Molodkin V; Friedman E; Zheleznova H; Malafeieva L; Peradze T; Beljakov V; Ivanov K
    Med Biol; 1975 Dec; 53(6):456-61. PubMed ID: 1214539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of the chromatographic purification of influenza viruses on porous silicate sorbents].
    Molodkin VM; Mchedlishvili BV; Katushkina NV; Zheleznova NV; Polianskaia NIu
    Tr Inst Im Pastera; 1976; 47():34-8. PubMed ID: 210541
    [No Abstract]   [Full Text] [Related]  

  • 14. [Detection of ovalbumin in influenza vaccine by electrosyneresis].
    Barme M
    Dev Biol Stand; 1977 Jun 1-3; 39():213-7. PubMed ID: 604099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Live influenza vaccine].
    Smorodintsev AA
    Vestn Akad Med Nauk SSSR; 1983; (12):15-21. PubMed ID: 6666315
    [No Abstract]   [Full Text] [Related]  

  • 16. Purification of human and avian influenza viruses using cellulose sulfate ester (Cellufine Sulfate) in the process of vaccine production.
    Sakoda Y; Okamatsu M; Isoda N; Yamamoto N; Ozaki K; Umeda Y; Aoyama S; Kida H
    Microbiol Immunol; 2012 Jul; 56(7):490-5. PubMed ID: 22530951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-ovalbumin sensitizing ability of influenza vaccines in guinea pigs.
    Weeke-Lüttmann M; Schramm-Thiel N
    Dev Biol Stand; 1977 Jun 1-3; 39():219-222. PubMed ID: 604100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitizing activity to egg protein of an A1PO4-adjuvant full-virus influenza vaccine.
    Nyerges G; Marton A; Korossy S; Vincze I
    Acta Microbiol Acad Sci Hung; 1982; 29(4):245-53. PubMed ID: 7185267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of the antigenic components of the host cell in isolated glycoproteins of the influenza virus].
    Rovnova ZI; Isaeva EI; Platonova AL; Rogacheva TA
    Vopr Virusol; 1988; 33(4):419-24. PubMed ID: 2461614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of different methods of determining ovalbumin in preparations of purified influenza virus].
    Bichurina MA; Goriunova VV; Chubarova NI; Zhebruk AB; Noskov FS
    Vopr Virusol; 1981; (2):228-30. PubMed ID: 6791386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.